Impact of Angiotensin II Receptor Blocker on Plasma Levels of Adiponectin and Advanced Oxidation Protein Products in Peritoneal Dialysis Patients

Publisher： Karger

E-ISSN： 1421-9735|24|5-6|445-450

ISSN： 0253-5068

Source： Blood Purification, Vol.24, Iss.5-6, 2006-12, pp. : 445-450

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effect of Angiotensin II Receptor Blocker on Plasma Levels of TGF-β1 and Interstitial Fibrosis in Hypertensive Kidney Transplant Patients

By  

American Journal of Nephrology, Vol. 23, Iss. 5, 2003-09 ,pp. : 300-306

Karger

Access to resources Recommend Favorite

Impact of Renin-Angiotensin Aldosterone System Inhibition on Serum Potassium Levels among Peritoneal Dialysis Patients

By  

American Journal of Nephrology, Vol. 46, Iss. 2, 2017-07 ,pp. : 150-155

Karger

Access to resources Recommend Favorite

Does Renal Function Influence Plasma Levels of Advanced Glycation and Oxidation Protein Products in Patients with Chronic Rheumatic Diseases Complicated by Secondary Amyloidosis?

By  

Kidney and Blood Pressure Research, Vol. 30, Iss. 1, 2006-12 ,pp. : 1-7

Karger

Access to resources Recommend Favorite

Usual ACE Inhibitor Therapy in CKD Patients Is Associated with Lower Plasma Aldosterone Levels than Usual Angiotensin Receptor Blocker Therapy

By  

Kidney and Blood Pressure Research, Vol. 30, Iss. 5, 2007-07 ,pp. : 299-305

Karger

Access to resources Recommend Favorite

Advanced Glycation End Products and Advanced Oxidation Protein Products in Hemodialyzed Patients

By  

Blood Purification, Vol. 20, Iss. 6, 2003-01 ,pp. : 531-536

Karger

Access to resources Recommend Favorite